U.S. markets closed
  • S&P Futures

    3,791.50
    +1.00 (+0.03%)
     
  • Dow Futures

    30,792.00
    -36.00 (-0.12%)
     
  • Nasdaq Futures

    13,028.25
    +42.75 (+0.33%)
     
  • Russell 2000 Futures

    2,139.20
    -8.10 (-0.38%)
     
  • Crude Oil

    53.35
    +0.37 (+0.70%)
     
  • Gold

    1,849.10
    +8.90 (+0.48%)
     
  • Silver

    25.50
    +0.18 (+0.73%)
     
  • EUR/USD

    1.2148
    +0.0015 (+0.12%)
     
  • 10-Yr Bond

    1.0920
    -0.0050 (-0.46%)
     
  • Vix

    23.24
    -1.10 (-4.52%)
     
  • GBP/USD

    1.3653
    +0.0019 (+0.14%)
     
  • USD/JPY

    103.7480
    -0.1440 (-0.14%)
     
  • BTC-USD

    35,243.82
    -650.43 (-1.81%)
     
  • CMC Crypto 200

    696.77
    -18.42 (-2.58%)
     
  • FTSE 100

    6,712.95
    -7.70 (-0.11%)
     
  • Nikkei 225

    28,482.00
    -151.46 (-0.53%)
     

Globus Medical Inc (GMED) President, CEO David M Demski Sold $13.9 million of Shares

GuruFocus.com
·1 min read

- By insider

President, CEO of Globus Medical Inc (30-Year Financial, Insider Trades) David M Demski (insider trades) sold 217,075 shares of GMED on 12/17/2020 at an average price of $64.2 a share. The total sale was $13.9 million.


Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment. Globus Medical Inc has a market cap of $6.45 billion; its shares were traded at around $65.370000 with a P/E ratio of 71.07 and P/S ratio of 8.58. Globus Medical Inc had annual average EBITDA growth of 7.00% over the past ten years. GuruFocus rated Globus Medical Inc the business predictability rank of 5-star. GuruFocus has detected 2 severe warning signs with Globus Medical Inc. .

CEO Recent Trades:

  • President, CEO David M Demski sold 217,075 shares of GMED stock on 12/17/2020 at the average price of $64.2. The price of the stock has increased by 1.82% since.

Directors and Officers Recent Trades:

  • Director David D Davidar sold 42,000 shares of GMED stock on 11/24/2020 at the average price of $60. The price of the stock has increased by 8.95% since.

For the complete insider trading history of GMED, click here

.This article first appeared on GuruFocus.